Skip to main content
Log in

Approach to a Child with Congestive Heart Failure

  • Review
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Pediatric heart failure (PHF) is an important cause of mortality and morbidity. Whereas ischemic heart disease is the most important cause of heart failure in adults, congenital heart diseases (CHD) and cardiomyopathies are important etiologies of PHF. Management of PHF also differs from that of adults. Here authors have reviewed the literature on PHF with respect to etiology, symptoms, investigations and treatment strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Caviedes Bottner P, Córdova Fernández T, Larraín Valenzuela M; Cruces Romero Presentación de Casos Clínicos P. Dilated cardiomyopathy and severe heart failure An update for pediatricians. Arch Argent Pediatr. 2018;116:e421–8.

  2. Webster G, Zhang J, Rosenthal D. Comparison of the epidemiology and co-morbidities of heart failure in the pediatric and adult populations: a retrospective, cross-sectional study. BMC Cardiovasc Disord. 2006;6:23.

    PubMed  PubMed Central  Google Scholar 

  3. Sommers C, Nagel BHP, Neudorf U, Schmaltz AA. Congestive heart failure in childhood. An epidemiologic study. Herz. 2005;30:652–62.

    PubMed  Google Scholar 

  4. Massin MM, Astadicko I, Dessy H. Epidemiology of heart failure in a tertiary pediatric center. Clin Cardiol. 2008;31:388–91.

    PubMed  PubMed Central  Google Scholar 

  5. Wray J, Sensky T. Congenital heart disease and cardiac surgery in childhood: effects on cognitive function and academic ability. Heart Br Card Soc. 2001;85:687–91.

    CAS  Google Scholar 

  6. Khairy P, Fernandes SM, Mayer JE, et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2008;117:85–92.

    PubMed  Google Scholar 

  7. Ross RD, Bollinger RO, Pinsky WW. Grading the severity of congestive heart failure in infants. Pediatr Cardiol. 1992;13:72–5.

    CAS  PubMed  Google Scholar 

  8. Bernstein D, Naftel D, Chin C, et al. Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study. Circulation. 2006;114:273–80.

    CAS  PubMed  Google Scholar 

  9. Nir A, Nasser N. Clinical value of NT-ProBNP and BNP in pediatric cardiology. J Card Fail. 2005;11:S76–80.

    CAS  PubMed  Google Scholar 

  10. Ko HK, Lee JH, Choi BM, et al. Utility of the rapid B-type natriuretic peptide assay for detection of cardiovascular problems in newborn infants with respiratory difficulties. Neonatology. 2008;94:16–21.

    CAS  PubMed  Google Scholar 

  11. Price JF, Thomas AK, Grenier M, et al. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction. Circulation. 2006;114:1063–9.

    CAS  PubMed  Google Scholar 

  12. Rodriguez W, Selen A, Avant D, et al. Improving pediatric dosing through pediatric initiatives: what we have learned. Pediatrics. 2008;121:530–9.

    PubMed  Google Scholar 

  13. Schweigmann U, Meierhofer C. Strategies for the treatment of acute heart failure in children. Minerva Cardioangiol. 2008;56:321–33.

    CAS  PubMed  Google Scholar 

  14. Hoffman TM, Wernovsky G, Atz AM, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation. 2003;107:996–1002.

    CAS  PubMed  Google Scholar 

  15. Rognoni A, Lupi A, Lazzero M, Bongo AS, Rognoni G. Levosimendan: from basic science to clinical trials. Recent Pat Cardiovasc Drug Discov. 2011;6:9–15.

    CAS  PubMed  Google Scholar 

  16. Faris R, Flather M, Purcell H, Henein M, Poole-Wilson P, Coats A. Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. Int J Cardiol. 2002;82:149–58.

    CAS  PubMed  Google Scholar 

  17. Prandota J. Clinical pharmacology of furosemide in children: a supplement. Am J Ther. 2001;8:275–89.

    CAS  PubMed  Google Scholar 

  18. Robertson CMT, Tyebkhan JM, Peliowski A, Etches PC, Cheung P-Y. Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure. Acta Paediatr Oslo Nor. 2006;95:214–23.

    Google Scholar 

  19. Engle MA, Lewy JE, Lewy PR, Metcoff J. The use of furosemide in the treatment of edema in infants and children. Pediatrics. 1978;62:811–8.

    CAS  PubMed  Google Scholar 

  20. Zannad F, Alla F, Dousset B, Perez A, Pitt B; Rales Investigators. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Circulation. 2000;102:2700–6.

    CAS  PubMed  Google Scholar 

  21. Momma K. ACE inhibitors in pediatric patients with heart failure. Paediatr Drugs. 2006;8:55–69.

    PubMed  Google Scholar 

  22. Buchhorn R, Hulpke-Wette M, Hilgers R, Bartmus D, Wessel A, Bürsch J. Propranolol treatment of congestive heart failure in infants with congenital heart disease: the CHF-PRO-INFANT trial. Congestive heart failure in infants treated with propanol. Int J Cardiol. 2001;79:167–73.

    CAS  PubMed  Google Scholar 

  23. Hastings SG, Johnston DJ, Blouin LT. Diuretic therapy in experimental right heart failure of the rhesus monkey. J Pharmacol Exp Ther. 1972;180:748–53.

    CAS  PubMed  Google Scholar 

  24. Norozi K, Buchhorn R, Wessel A, et al. Beta-blockade does not alter plasma cytokine concentrations and ventricular function in young adults with right ventricular dysfunction secondary to operated congenital heart disease. Circ J. 2008;72:747–52.

    CAS  PubMed  Google Scholar 

  25. Rosenthal D, Chrisant MRK, Edens E, et al. International Society for Heart and Lung Transplantation: practice guidelines for management of heart failure in children. J Heart Lung Transplant. 2004;23:1313–33.

    PubMed  Google Scholar 

  26. Anderson PAW, Sleeper LA, Mahony L, et al. Contemporary outcomes after the Fontan procedure: a pediatric heart network multicenter study. J Am Coll Cardiol. 2008;52:85–98.

    PubMed  PubMed Central  Google Scholar 

  27. Hsu DT, Zak V, Mahony L, et al. Enalapril in infants with single ventricle: results of a multicenter randomized trial. Circulation. 2010;122:333–40.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Shaddy RE, Boucek MM, Hsu DT, et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA. 2007;298:1171–9.

    PubMed  Google Scholar 

  29. Huang M, Zhang X, Chen S, et al. The effect of carvedilol treatment on chronic heart failure in pediatric patients with dilated cardiomyopathy: a prospective, randomized-controlled study. Pediatr Cardiol. 2013;34:680–5.

    PubMed  Google Scholar 

  30. Frobel A-K, Hulpke-Wette M, Schmidt KG, Läer S. Beta-blockers for congestive heart failure in children. Cochrane Database Syst Rev. 2009;1:CD007037.

    Google Scholar 

  31. Connolly D, Rutkowski M, Auslender M, Artman M. The New York University pediatric heart failure index: a new method of quantifying chronic heart failure severity in children. J Pediatr. 2001;138:644–8.

    CAS  PubMed  Google Scholar 

  32. Epstein AE, Dimarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary. Heart Rhythm. 2008;5:934–55.

    PubMed  Google Scholar 

  33. Berul CI, Van Hare GF, Kertesz NJ, et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol. 2008;51:1685–91.

    PubMed  Google Scholar 

  34. Cecchin F, Frangini PA, Brown DW, et al. Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution. J Cardiovasc Electrophysiol. 2009;20:58–65.

    PubMed  Google Scholar 

  35. Dubin AM, Janousek J, Rhee E, et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol. 2005;46:2277–83.

    PubMed  Google Scholar 

  36. Blume ED, Naftel DC, Bastardi HJ, et al. Outcomes of children bridged to heart transplantation with ventricular assist devices: a multi-institutional study. Circulation. 2006;113:2313–9.

    PubMed  Google Scholar 

  37. Gandhi SK, Huddleston CB, Balzer DT, Epstein DJ, Boschert TA, Canter CE. Biventricular assist devices as a bridge to heart transplantation in small children. Circulation. 2008;118:S89–93.

    PubMed  Google Scholar 

  38. Rockett SR, Bryant JC, Morrow WR, et al. Preliminary single center North American experience with the Berlin Heart pediatric EXCOR device. J Am Soc Artif Intern Organs. 2008;54:479–82.

    Google Scholar 

  39. Baldwin JT, Borovetz HS, Duncan BW, et al. The National Heart, Lung, and Blood Institute pediatric circulatory support program. Circulation. 2006;113:147–55.

    PubMed  Google Scholar 

  40. Benden C, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: sixteenth official pediatric lung and heart-lung transplantation report--2013; focus theme: age. J Heart Lung Transplant. 2013;32:989–97.

    PubMed  Google Scholar 

  41. Manlhiot C, Pollock-Barziv SM, Holmes C, et al. Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients. J Heart Lung Transplant. 2010;29:648–57.

    PubMed  Google Scholar 

  42. Rhodes J, Curran TJ, Camil L, et al. Sustained effects of cardiac rehabilitation in children with serious congenital heart disease. Pediatrics. 2006;118:e586–93.

    PubMed  Google Scholar 

  43. Akagi T, Benson LN, Lightfoot NE, Chin K, Wilson G, Freedom RM. Natural history of dilated cardiomyopathy in children. Am Heart J. 1991;121:1502–6.

    CAS  PubMed  Google Scholar 

  44. Almond CSD, Thiagarajan RR, Piercey GE, et al. Waiting list mortality among children listed for heart transplantation in the United States. Circulation. 2009;119:717–27.

    PubMed  PubMed Central  Google Scholar 

  45. Swedberg K, Komajda M, Böhm M, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet Lond Engl. 2010;376:875–85.

    CAS  Google Scholar 

  46. McMurray JJV, Packer M, Desai AS, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371:993–1004.

    PubMed  Google Scholar 

  47. Pillekamp F, Khalil M, Emmel M, Brockmeier K, Hescheler J. Stem cells in pediatric heart failure. Minerva Cardioangiol. 2008;56:335–48.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Both authors contributed in the writing article. MR is the guarantor for this paper.

Corresponding author

Correspondence to Manojkumar Rohit.

Ethics declarations

Conflict of Interest

None.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rohit, M., Budakoty, S. Approach to a Child with Congestive Heart Failure. Indian J Pediatr 87, 312–320 (2020). https://doi.org/10.1007/s12098-020-03255-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-020-03255-6

Keywords

Navigation